Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-122115

Director bought 15,000 shares at $1.56 ($23,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2016-05-19 Purchase +15,000 $1.56 $23,400 314,100 I
Open-market purchases · 15,000 sh · avg $1.56 · $23,400
Loading xslF345X03/a4.xml…